1. Safety, pharmacokinetics and pharmacodynamics of TAK‐418, a novel inhibitor of the epigenetic modulator lysine‐specific demethylase 1A. Issue 12 (10th June 2021) Authors: Yin, Wei; Arkilo, Dimitrios; Khudyakov, Polyna; Hazel, Jim; Gupta, Saurabh; Quinton, Maria S.; Lin, Jie; Hartman, Deborah S.; Bednar, Martin M.; Rosen, Laura; Wendland, Jens R. Journal: British journal of clinical pharmacology Issue: Volume 87:Issue 12(2021) Page Start: 4756 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗